Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of MDI-1228 mesylate gel in diabetic foot ulcer
CTR20262604Phase 2Active
- Sponsor
- Mainuo Pharmaceutical
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MDI-1228 in diabetic foot ulcer (DFU), sponsored by Mainuo Pharmaceutical. Started Jul 2026; status: active.
02
Drugs
MDI-1228
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on CTR20262604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262604.